Engineering Sweetness After Sucrose · Molecular Design, Enzymatic Bioconversion, Rare Sugars, Sweet Proteins and the European Regulatory Frontier

Sugar reduction is commonly approached as a substitution problem: the technologist removes sucrose, selects a high-intensity sweetener and restores sweetness until the analytical specification has been met. This interpretation is inadequate because sucrose performs at least four simultaneous functions in foods: sensory signalling, bulk and osmotic structuring, physicochemical control, and participation in chemical reactions during processing. Contemporary ingredient biotechnology offers a more complex repertoire, comprising highly purified steviol glycosides manufactured through enzymatic conversion, low-abundance monosaccharides such as D-tagatose and D-allulose, fermentation-derived polyols, and intensely sweet proteins. These ingredient families cannot be treated as interchangeable. Their metabolic fate, sweetness kinetics, solvent behaviour, thermal robustness, microbiological implications and legal identities are distinct. In 2026, a systematic review of 20 controlled human trials involving 1,033 participants reported attenuation of acute postprandial glycaemic responses after allulose or tagatose exposure but did not establish consistent benefits for longer-term lipid or body-composition outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24340160
Primary Topic
Biochemical Analysis and Sensing Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Engineering Sweetness After Sucrose · Molecular Design, Enzymatic Bioconversion, Rare Sugars, Sweet Proteins and the European Regulatory Frontier

Jose Manuel López
3 links
Zenodo (CERN European Organization for Nuclear Research)
Biochemical Analysis and Sensing Techniques
article

Engineering Sweetness After Sucrose · Molecular Design, Enzymatic Bioconversion, Rare Sugars, Sweet Proteins and the European Regulatory Frontier

Jose Manuel López
article en

Abstract

Sugar reduction is commonly approached as a substitution problem: the technologist removes sucrose, selects a high-intensity sweetener and restores sweetness until the analytical specification has been met. This interpretation is inadequate because sucrose performs at least four simultaneous functions in foods: sensory signalling, bulk and osmotic structuring, physicochemical control, and participation in chemical reactions during processing. Contemporary ingredient biotechnology offers a more complex repertoire, comprising highly purified steviol glycosides manufactured through enzymatic conversion, low-abundance monosaccharides such as D-tagatose and D-allulose, fermentation-derived polyols, and intensely sweet proteins. These ingredient families cannot be treated as interchangeable. Their metabolic fate, sweetness kinetics, solvent behaviour, thermal robustness, microbiological implications and legal identities are distinct. In 2026, a systematic review of 20 controlled human trials involving 1,033 participants reported attenuation of acute postprandial glycaemic responses after allulose or tagatose exposure but did not establish consistent benefits for longer-term lipid or body-composition outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Biochemical Analysis and Sensing Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon